Quantitative assessment of minimal residual disease for monitoring of paediatric patients with relapsed/refractory anaplastic large‐cell lymphoma treated with brentuximab vedotin: A case series
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19151 ↗Kurz gefasst
Leserbrief in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Giorgia Contarini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Maternal and Child Health Department Pediatric Hematology, Oncology and Stem Cell Transplant Center, University of Padua, Padua, Italy. Hauptthemen laut MEDLINE: Lymphoma, Large-Cell, Anaplastic, Hodgkin Disease, Immunoconjugates. Die Arbeit nennt 15 Literaturangaben. Gefördert von: AIRC by Associazione Italiana per la Ricerca sul Cancro.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Maternal and Child Health Department Pediatric Hematology, Oncology and Stem Cell Transplant Center, University of Padua, Padua, Italy.
- Pediatric Research Institute "Città della Speranza", Padua, Italy.
- Center of Pediatric Hematology-Oncology, Azienda Policlinico-San Marco, Catania, Italy.
- Department of Pediatric Hematology Oncology, Fondazione IRCCS San Gerardo dei Tintori, Centro Maria Letizia Verga, University of Milano-Bicocca, Monza, Italy.
ORCID-Profile: Luca Lo Nigro, Marta Pillon, Lara Mussolin
Förderung
- AIRC by Associazione Italiana per la Ricerca sul Cancro
Zitieren
APA
Contarini, G., Carraro, E., Lovisa, F., Martire, G., Lo Nigro, L., Sala, A., Pillon, M., & Mussolin, L. (2024). Quantitative assessment of minimal residual disease for monitoring of paediatric patients with relapsed/refractory anaplastic large‐cell lymphoma treated with brentuximab vedotin: A case series. British Journal of Haematology. https://doi.org/10.1111/bjh.19151
Vancouver
Contarini G, Carraro E, Lovisa F, Martire G, Lo Nigro L, Sala A, et al. Quantitative assessment of minimal residual disease for monitoring of paediatric patients with relapsed/refractory anaplastic large‐cell lymphoma treated with brentuximab vedotin: A case series. British Journal of Haematology. 2024. doi:10.1111/bjh.19151
BibTeX
@article{Contarini2024,
author = {Contarini, Giorgia and Carraro, Elisa and Lovisa, Federica and Martire, Gaia and Lo Nigro, Luca and Sala, Alessandra and Pillon, Marta and Mussolin, Lara},
title = {Quantitative assessment of minimal residual disease for monitoring of paediatric patients with relapsed/refractory anaplastic large‐cell lymphoma treated with brentuximab vedotin: A case series},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19151}
}
EUVIMED